SODERMIX® Soothing repairing cream, was created originally for prevention and treatment of keloids and hypertrophic scars. SODERMIX® Cream, based on a patented active ingredient: Vegetal Superoxide Dismutase (SOD), has demonstrated that it works perfectly in various clinical indications, like pruritus, side effects of radiotherapy, burns and for treatment of atopic dermatitis in children.

SODERMIX® Crema reparadora calmante, fue creada originalmente para la Prevención y el tratamiento de queloides y cicatrices hipertróficas. SODERMIX® Crema basada en un activo patentado: Superóxido dismutasa vegetal (SOD), ha demostrado que funciona perfectamente en varias indicaciones, como prurito, efectos secundarios de la radioterapia, quemaduras y para el tratamiento de la dermatitis atópica en niños.

SODERMIX® Cream has shown significant improvements after 90 days of use, in the following clinical cases:

Keloid and Hypertrophic Scars

Keloid Scars after plastic surgeries

Wound healing

Atopic dermatitis

Contact dermatitis

Eczema Nummularis

Epidermolysis bullosa

Tuberous fibrosis

Burns

Radiotherapy

Facial moles

SODERMIX® Crema ha demostrado mejoras significativas luego de los 90 días de uso, en los siguientes casos clínicos:
Cicatrices queloides e hipertróficas.
Cortesia Dr V. Gross

Cicatrices queloides después de cirugías plásticas
Cortesia Dra. M. Jovick

Curación de heridas

Dermatitis atópica

Dermatitis de Contacto

Eczema Nummularis

Epidermólisis Ampollosa

Fibrosis Tuberosa
Quemaduras

Radioterapia

Lunares faciales
For more information send us an email to: info@lifescienceinvestments.com
5 Comments on Know the clinical evidence, Before & after with SODERMIX® Cream

5 Replies to “Know the clinical evidence, Before & after with SODERMIX® Cream”

  1. I’m extremely pleased to discover this website. I wanted to thank you for ones time just for this fantastic read!! I absolutely enjoyed every part of it and i also have you bookmarked to see new stuff in your site.

Leave a Reply

Your email address will not be published. Required fields are marked *